3 research outputs found
Anestesia por infusão contínua de propofol associado ao remifentanil em gatos pré-tratados com acepromazina
O presente trabalho avaliou a associação anestésica do propofol, um anestésico geral de ação ultracurta e metabolismo rápido, ao remifentanil, opioide de grande poder analgésico, que potencializa os anestésicos gerais. O objetivo principal foi desenvolver um protocolo anestésico de uso intravenoso, por infusão contínua, que proporcione conforto ao paciente, segurança, com grande relaxamento muscular e analgesia em gatos submetidos a cirurgias eletivas como a ovariosalpingoisterectomia e orquiectomia. Foram utilizados 30 gatos, aleatoriamente distribuídos em 3 grupos de 10 animais. Em todos eles realizou-se a tranquilização com acepromazina (0,1 mg/kg, IM) e indução anestésica com propofol (6 mg/kg, IV). No grupo 1, a anestesia foi mantida por infusão contínua de propofol (0,6 mg/kg/min), no grupo 2, com propofol (0,4 mg/kg/min) e remifentanil (0,1 µg/kg/min), e no grupo 3, com propofol (0,4 mg/kg/min) e remifentanil (0,2 µg/kg/min). As variáveis mensuradas foram: temperatura corporal, frequência cardíaca, frequência respiratória, saturação da oxiemoglobina, pressão arterial sistólica, hemogasometria arterial, analgesia e miorrelaxamento. Após análise dos resultados, pode-se concluir que o remifentanil promoveu incremento da analgesia, permitindo redução de 33% na velocidade de infusão do propofol, entretanto a infusão de 0,2 µg/kg/min de remifentanil determinou maior depressão respiratória quando comparada à infusão de 0,1 µg/kg/min.The present work evaluated the anesthetic association of propofol, an ultra-short acting general anesthetic with a fast metabolism, with remifentanil, an opioid of great analgesic potency that is used as adjunct to general anesthetics. The main objective was to develop a safe protocol of intravenous continuous infusion capable of providing comfort for the patient with great analgesic action and muscle relaxation for cats subjected to elective surgeries like ovariohysterectomy and orchiectomy. Thirty cats were randomly distributed in 3 groups of 10 animals each. All animals were tranquilized with acepromazine (0.1 mg/kg IM) and general anesthesia was induced using propofol (6mg/kg, IV). In group 1, general anesthesia was maintained by continuous infusion of propofol (0.6 mg/kg/min); in group 2, with propofol (0.4 mg/kg/min) and remifentanil (0.1 µg/kg/min) and; in group 3, with propofol (0.4 mg/kg/min) and remifentanil (0.2 µg/kg/min). The measured variables were: temperature, heart rate, respiratory rate, oxyhemoglobin saturation, systolic arterial pressure, arterial blood gas analysis, analgesia and myorelaxation. Results of the analyses led to the conclusion that remifentanil promoted an increase in analgesia, allowing a 33% reduction on the rate of propofol infusion, although the infusion of 0.2 µg/kg/min of remifentanil determined a greater respiratory depression when compared to the 0.1 µg/kg/min infusion
Novel Scaffold Based on Chitosan Hydrogels/Phthalated Cashew Gum for Supporting Human Dental Pulp Stem Cells
Hydrogels are structures that have value for application in the area of tissue engineering because they mimic the extracellular matrix. Naturally obtained polysaccharides, such as chitosan (CH) and cashew gum, are materials with the ability to form polymeric networks due to their physicochemical properties. This research aimed to develop a scaffold based on chitosan and phthalated cashew tree gum and test it as a support for the growth of human mesenchymal stem cells. In this study, phthalation in cashew gum (PCG) was performed by using a solvent-free route. PCG-CH scaffold was developed by polyelectrolyte complexation, and its ability to support adherent stem cell growth was evaluated. The scaffold showed a high swelling rate. The pore sizes of the scaffold were analyzed by scanning electron microscopy. Human dental pulp stem cells (hDPSCs) were isolated, expanded, and characterized for their potential to differentiate into mesenchymal lineages and for their immunophenotypic profile. Isolated mesenchymal stem cells presented fibroblastoid morphology, plastic adhesion capacity, and differentiation in osteogenic, adipogenic, and chondrogenic lineages. Mesenchymal stem cells were cultured in scaffolds to assess cell adhesion and growth. The cells seeded on the scaffold showed typical morphology, attachment, and adequate distribution inside the matrix pores. Thus, cells seeded in the scaffold may improve the osteoinductive and osteoconductive properties of these biomaterials